Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Assay Type

  2.3.2 Market Size By Product & Service

  2.3.3 Market Size By Cell Therapy Type

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1. Raw Material & Reagent Suppliers
3.4.2. Assay Kit & Instrument Manufacturers
3.4.3. Contract Testing & Service Providers
3.4.4. Cell Therapy Developers & End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Assay Performance & Accuracy Metrics

  4.1.1 Average Assay Sensitivity Across Different Potency Test Methods (%)

  4.1.2 Percentage Improvement in Assay Reproducibility Through Standardization (%)

  4.1.3 Average Time-to-Result for Potency Assays (Hours)

  4.1.4 Share of Potency Assays Meeting Regulatory (e.g., FDA, EMA) Acceptance Criteria (%)

  4.1.5 Average Assay Specificity Rate in Identifying Active Cell Populations (%)

 4.2 Technology Adoption & Platform Trends

  4.2.1 Share of Laboratories Adopting Automated Potency Assay Platforms (%)

  4.2.2 Percentage of Potency Assays Utilizing High-Content Imaging Techniques (%)

  4.2.3 Growth in Adoption of Label-Free Assay Technologies for Potency Testing (%)

  4.2.4 Share of Multiplex Assays Used for Comprehensive Potency Profiling (%)

  4.2.5 Average Reduction in Assay Variability with AI-Assisted Data Analysis (%)

 4.3 Workflow Efficiency & Operational Metrics

  4.3.1 Average Number of Samples Processed Per Day in High-Throughput Potency Testing

  4.3.2 Percentage Reduction in Manual Intervention in Potency Assay Workflows (%)

  4.3.3 Average Cost-Per-Assay in Contract Testing Laboratories (USD)

  4.3.4 Share of Potency Testing Outsourced to CDMOs & CROs (%)

  4.3.5 Average Turnaround Time for Potency Assay Results from External Service Providers (Days)

 4.4 Regulatory Compliance & Quality Control Indicators

  4.4.1 Share of Potency Assays Validated per ICH Q2 Guidelines (%)

  4.4.2 Percentage of Cell Therapy Products Utilizing Reference Standards for Potency (%)

  4.4.3 Average Frequency of Assay Re-qualification in Quality Control Laboratories (Months)

  4.4.4 Share of Assays Incorporating In-Process Controls for Real-Time Potency Monitoring (%)

  4.4.5 Percentage Reduction in Failed Batch Releases Due to Enhanced Potency Assays (%)

5. Cell Therapy Potency Assays Market Segmental Analysis & Forecast, By Assay Type, 2022–2035, Value (USD Billion)

 5.1 Introduction
 5.2 Cell-Based Assays
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Reporter Gene Assays
 5.4 Binding & Immunoassays
 5.5 Molecular & Biochemical Assays

6. Cell Therapy Potency Assays Market Segmental Analysis & Forecast, By Product & Service, 2022–2035, Value (USD Billion)

 6.1 Introduction
 6.2 Kits & Reagents
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022–2035
 6.3 Instruments
 6.4 Services

7. Cell Therapy Potency Assays Market Segmental Analysis & Forecast, By Cell Therapy Type, 2022–2035, Value (USD Billion)

 7.1 Introduction
 7.2 CAR-T Cell Therapy
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022–2035
 7.3 Stem Cell Therapy
 7.4 TIL & NK Cell Therapy
 7.5 Dendritic Cell & Other Cell Therapies

8. Cell Therapy Potency Assays Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

 8.1 Introduction
 8.2 Pharmaceutical & Biotechnology Companies
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, 2022–2035
 8.3 CDMOs & CROs
 8.4 Academic & Research Institutes

9. Cell Therapy Potency Assays Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 Cell Therapy Potency Assays Market Size & Forecast, By Assay Type, 2022–2035

  9.2.3 Cell Therapy Potency Assays Market Size & Forecast, By Product & Service, 2022–2035

  9.2.4 Cell Therapy Potency Assays Market Size & Forecast, By Cell Therapy Type, 2022–2035

  9.2.5 Cell Therapy Potency Assays Market Size & Forecast, By End User, 2022–2035

  9.2.6 Cell Therapy Potency Assays Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 USA

   9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Cell Therapy Potency Assays Market Size & Forecast, By Assay Type, 2022–2035

 9.3.3 Cell Therapy Potency Assays Market Size & Forecast, By Product & Service, 2022–2035

 9.3.4 Cell Therapy Potency Assays Market Size & Forecast, By Cell Therapy Type, 2022–2035

 9.3.5 Cell Therapy Potency Assays Market Size & Forecast, By End User, 2022–2035

 9.3.6 Cell Therapy Potency Assays Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Cell Therapy Potency Assays Market Size & Forecast, By Assay Type, 2022–2035

 9.4.3 Cell Therapy Potency Assays Market Size & Forecast, By Product & Service, 2022–2035

 9.4.4 Cell Therapy Potency Assays Market Size & Forecast, By Cell Therapy Type, 2022–2035

 9.4.5 Cell Therapy Potency Assays Market Size & Forecast, By End User, 2022–2035

 9.4.6 Cell Therapy Potency Assays Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Cell Therapy Potency Assays Market Size & Forecast, By Assay Type, 2022–2035

 9.5.3 Cell Therapy Potency Assays Market Size & Forecast, By Product & Service, 2022–2035

 9.5.4 Cell Therapy Potency Assays Market Size & Forecast, By Cell Therapy Type, 2022–2035

 9.5.5 Cell Therapy Potency Assays Market Size & Forecast, By End User, 2022–2035

 9.5.6 Cell Therapy Potency Assays Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Cell Therapy Potency Assays Market Size & Forecast, By Assay Type, 2022–2035

 9.6.3 Cell Therapy Potency Assays Market Size & Forecast, By Product & Service, 2022–2035

 9.6.4 Cell Therapy Potency Assays Market Size & Forecast, By Cell Therapy Type, 2022–2035

 9.6.5 Cell Therapy Potency Assays Market Size & Forecast, By End User, 2022–2035

 9.6.6 Cell Therapy Potency Assays Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

  10.6.1 Charles River Laboratories International, Inc.

10.6.1.1 Company Overview & Snapshot

10.6.1.2 Product/Service Portfolio

10.6.1.3 Key Company Financials

10.6.1.4 Geographical Presence

10.6.1.5 SWOT Analysis

10.6.2 Lonza Group AG
10.6.3 Thermo Fisher Scientific Inc.
10.6.4 Sartorius AG
10.6.5 WuXi AppTec Co., Ltd.
10.6.6 Eurofins Scientific SE
10.6.7 Pharmaron Beijing Co., Ltd.
10.6.8 Danaher Corporation (Cytiva)
10.6.9 Bio-Techne Corporation
10.6.10 Revvity, Inc.
10.6.11 Promega Corporation
10.6.12 SGS SA
10.6.13 Intertek Group plc
10.6.14 Catalent, Inc.
10.6.15 Avantor, Inc.
10.6.16 Merck KGaA
10.6.17 Miltenyi Biotec B.V. & Co. KG
10.6.18 National Resilience, Inc.
10.6.19 ACROBiosystems
10.6.20 Cellistic (a Fujifilm company)

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures